ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,816
Screening encounters
4,484
Diagnostic referrals
853
Outstanding pathways
308

Screening pathway

  1. Screening4,484Encounters
  2. Positive finding1,547Documented findings
  3. Referral853Diagnostic referrals
  4. Follow-up1,012Diagnostic visits
  5. Outcome545Resolved pathways

Stage totals use different units. Pending pathways: 308. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2026-11-12, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3816 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4814 · Expanded synthetic participant 4814Site E — Resource-Constrained Navigation Programme
EXP-4815 · Expanded synthetic participant 4815Site D — Community Engagement Programme
EXP-4816 · Expanded synthetic participant 4816Site E — Resource-Constrained Navigation Programme
EXP-4817 · Expanded synthetic participant 4817Site A — Urban Referral Hub
EXP-4818 · Expanded synthetic participant 4818Site D — Community Engagement Programme
EXP-4819 · Expanded synthetic participant 4819Site A — Urban Referral Hub
EXP-4820 · Expanded synthetic participant 4820Site A — Urban Referral Hub
EXP-4821 · Expanded synthetic participant 4821Site B — Peri-Urban Access Programme
EXP-4822 · Expanded synthetic participant 4822Site D — Community Engagement Programme
EXP-4824 · Expanded synthetic participant 4824Site B — Peri-Urban Access Programme
EXP-4825 · Expanded synthetic participant 4825Site E — Resource-Constrained Navigation Programme
EXP-4826 · Expanded synthetic participant 4826Site D — Community Engagement Programme
EXP-4827 · Expanded synthetic participant 4827Site B — Peri-Urban Access Programme
EXP-4830 · Expanded synthetic participant 4830Site E — Resource-Constrained Navigation Programme
EXP-4831 · Expanded synthetic participant 4831Site E — Resource-Constrained Navigation Programme
EXP-4832 · Expanded synthetic participant 4832Site A — Urban Referral Hub
EXP-4833 · Expanded synthetic participant 4833Site C — Rural Outreach Programme
EXP-4835 · Expanded synthetic participant 4835Site E — Resource-Constrained Navigation Programme
EXP-4836 · Expanded synthetic participant 4836Site A — Urban Referral Hub
EXP-4837 · Expanded synthetic participant 4837Site D — Community Engagement Programme
EXP-4838 · Expanded synthetic participant 4838Site B — Peri-Urban Access Programme
EXP-4841 · Expanded synthetic participant 4841Site E — Resource-Constrained Navigation Programme
EXP-4842 · Expanded synthetic participant 4842Site B — Peri-Urban Access Programme
EXP-4843 · Expanded synthetic participant 4843Site E — Resource-Constrained Navigation Programme
EXP-4844 · Expanded synthetic participant 4844Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1722
HPV DNA
2132
Cytology
630

Navigation activity

Barrier documented
760
Contact attempt
1255
Navigation intervention
326
Diagnostic booking
1064
Diagnostic visit
1012

Documented barriers

Contact difficulty
246
Transport difficulty
250
Appointment coordination
264

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.